Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch
Join members of Sidley's Global Life Sciences team for a lunchtime CLE-accredited program during the JPM Healthcare Conference discussing the latest regulatory trends impacting the next wave of development-stage transactions. Led by Meena Datta, global co-leader of Sidley's Healthcare practice; Torrey Cope, partner in Sidley's Food Drug and Medical Device (FDMD) practice; and Sally Wagner […]
